Cencora, Inc.
COR · CIK 0001140859 · Wholesale-Drugs, Proprietaries & Druggists' Sundries
About Cencora, Inc.
Business Overview
Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. We deliver innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain in both human and animal health.
Business information sourced from SEC annual filing filed Nov 25, 2025. Business descriptions reflect the cited filing and may not describe subsequent changes.
Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.
Company Details
- Registered name
- Cencora, Inc.
- Ticker symbol
- COR
- CIK
- 0001140859
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC SIC code
- 5122
- Fiscal year end (MMDD)
- 0930
- Last SEC synchronization
- Nov 8, 2026 16:16 UTC
Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Official website, business descriptions and executive details require separate verification.
Financial highlights
Latest qualifying annual SEC observations · USDHistorical financial performance
USD billions · Annual SEC observations · Choose a metric
Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.
Annual financial history
USD · Exact fiscal period ends| Period ended | Revenue | Net income | Operating income | Assets | Liabilities | Cash | Operating cash flow | Net margin |
|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2025 | $321.33B | $1.55B | $2.63B | $76.59B | — | $4.36B | $3.88B | 0.5% |
| Sept. 30, 2024 | $293.96B | $1.51B | $2.18B | $67.10B | — | $3.13B | $3.48B | 0.5% |
| Sept. 30, 2023 | $262.17B | $1.75B | $2.34B | $62.56B | — | $2.59B | $3.91B | 0.7% |
| Sept. 30, 2022 | $238.59B | $1.70B | $2.37B | $56.56B | — | $3.39B | $2.70B | 0.7% |
| Sept. 30, 2021 | $213.99B | $1.54B | $2.35B | $57.34B | — | $2.55B | $2.67B | 0.7% |
| Sept. 30, 2020 | $189.89B | −$3.41B | −$5.14B | $44.27B | — | $4.60B | $2.21B | -1.8% |
| Sept. 30, 2019 | $179.59B | $855.36M | $1.11B | $39.17B | — | $3.37B | $2.34B | 0.5% |
| Sept. 30, 2018 | $167.94B | $1.66B | $1.44B | $37.67B | — | $2.49B | $1.41B | 1.0% |
A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.
Latest SEC filings
Browse filings →| Form | Filed | Report period | Official source |
|---|---|---|---|
| 8-K | Nov. 4, 2026 | Nov. 4, 2026 | View SEC filing ↗ |
| 8-K | Nov. 4, 2026 | Nov. 4, 2026 | View SEC filing ↗ |
| 8-K | Oct. 21, 2026 | Oct. 21, 2026 | View SEC filing ↗ |
| 8-K | Sept. 25, 2026 | Sept. 24, 2026 | View SEC filing ↗ |
| 8-K | Aug. 14, 2026 | Aug. 13, 2026 | View SEC filing ↗ |
| 8-K | Aug. 12, 2026 | Aug. 12, 2026 | View SEC filing ↗ |
| 8-K | Aug. 5, 2026 | Aug. 5, 2026 | View SEC filing ↗ |
| 8-K | Aug. 5, 2026 | July 31, 2026 | View SEC filing ↗ |
| 8-K | June 15, 2026 | June 10, 2026 | View SEC filing ↗ |
| 8-K | May 29, 2026 | May 23, 2026 | View SEC filing ↗ |
| 8-K | May 6, 2026 | May 6, 2026 | View SEC filing ↗ |
| 8-K | March 23, 2026 | March 21, 2026 | View SEC filing ↗ |
| 8-K | March 17, 2026 | March 17, 2026 | View SEC filing ↗ |
| 8-K | March 6, 2026 | March 5, 2026 | View SEC filing ↗ |
| 8-K | Feb. 18, 2026 | Feb. 17, 2026 | View SEC filing ↗ |
| 8-K | Feb. 13, 2026 | Feb. 13, 2026 | View SEC filing ↗ |
| 8-K | Feb. 11, 2026 | Feb. 10, 2026 | View SEC filing ↗ |
| 8-K | Feb. 10, 2026 | Feb. 10, 2026 | View SEC filing ↗ |
| 8-K | Feb. 4, 2026 | Feb. 2, 2026 | View SEC filing ↗ |
| 8-K | Jan. 22, 2026 | Jan. 20, 2026 | View SEC filing ↗ |
Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.